• Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, 050051, P.R.China;
LIU Lijun, Email: hbghxiongwaike@126.com
Export PDF Favorites Scan Get Citation

Objective  To explore the feasibility of establishing a rabbit model of flail chest. Methods  Flail chest model was eatablished in 12 New Zealand white rabbits after anesthesia and sterile surgery. The paradoxical movement of chest wall was recorded by the biological signal acquisition system, arterial blood was collected for blood gas analysis, the vital signs were recorded by electrocardiogram (ECG) and the lung tissue was taken for the pathological analysis at the end of the experiment. The effect of flail chest on the respiratory function of experimental animals was analyzed to evaluate the feasibility of establishing flail chest model. Results  All surgeries were successful without mortality. The operation time was 41.42±7.08 min. Duration of endotracheal intubation was 79.33±12.21 min. Statistical results showed that the pH, partial pressure of arterial carbon dioxide (PaCO2) and base excess (BE) increased; while partial pressure of oxygen (PaO2) and oxygen saturation (SaO2) reduced. Pathological results showed that flail chest not intervented for a long period would lead to organic lesions. Conclusion  The rabbit model of flail chest is feasible, safe, repeatable, easy and simple to handle. The animal is easy to access which is the foundation to study the disease process, recovery procedure and the efficacy after intervention.

Citation: ZHANG Yaochao, ZHANG Han, LIU Lijun, SONG Yongbin, ZHANG Guibin, CUI Hongshang. Establishment of flail chest in a rabbit model. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(2): 159-163. doi: 10.7507/1007-4848.201611007 Copy

  • Previous Article

    Current situation of breast conserving surgery after neoadjuvant chemotherapy
  • Next Article

    Therapeutic effect of endocrine therapy in breast cancer patients with negative hormone receptor of primary lesion and positive hormone receptor of metastatic axillary lymph node lesion